Workflow
Tou Bao Yan Jiu Yuan
icon
Search documents
中国钠离子电池储能行业市场规模测算逻辑模型 头豹词条报告系列
Tou Bao Yan Jiu Yuan· 2025-03-11 11:43
中国钠离子电池储能行业市场规模 测算逻辑模型 头豹词条报告系列 寿珂可 钠离子电池储能行业规模 | 1. 中国钠离子储能市场规模预测 (结论图) | P3 | | --- | --- | | 2. 中国钠离子储能市场规模预测 | P4 | | 3. 飞轮储能单位功率初次投资成本 | P5 | | 4. 中国飞轮储能渗透率 | P6 | | 5. 中国飞轮储能累计装机规模 | P7 | | 6. 中国飞轮储能市场规模 | P8 | | 7. 溯源信息链接引用 | P9 | | 8. 法律声明 | P10 | | 9. 头豹研究院简介 | P11 | | 10. 头豹词条介绍 | P12 | | 11. 头豹词条报告 | P13 | 1. 中国钠离子储能市场规模预测 (结论图) P3 2. 中国钠离子储能市场规模预测 P4 | 中国钠离子储能市场规模预测:(结论=D*(1.1/0.2)) 中国钠离子储能市场规模预测:(结论=D*(1.1/0.2)) | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ...
AI医疗器械爆发前夜:医学影像与诊断设备引领千亿级市场变革 头豹词条报告系列
Tou Bao Yan Jiu Yuan· 2025-03-10 12:52
Investment Rating - The report indicates a positive outlook for the AI medical device industry, highlighting its potential for significant growth and market expansion due to technological advancements and regulatory support [1]. Core Insights - The AI medical device industry is on the verge of a breakthrough, driven by the commercialization of artificial intelligence technology and increasing regulatory approvals for various products [1][30]. - The market size of AI medical devices has grown from 1.25 billion RMB in 2019 to 4.37 billion RMB in 2023, with a compound annual growth rate (CAGR) of 143.33% [30]. - The industry is expected to continue expanding, with projections indicating a market size of 52.49 billion RMB by 2028, reflecting a CAGR of 68.58% [30]. Industry Definition - AI medical devices are defined as medical devices that utilize medical device data and artificial intelligence technology to achieve their intended medical purposes [2]. Industry Classification - AI medical devices can be classified based on their intended use into two categories: decision-supporting and non-decision-supporting devices [4][6]. Industry Characteristics - The AI medical device industry is characterized by its wide application across various medical fields, a diverse range of participating companies, and a steady increase in the number of approved Class III medical device registrations [8]. - The number of approved Class III medical devices has shown consistent growth, with 81 AI medical devices approved by the end of 2023, marking a significant increase from previous years [11][18]. Development History - The AI medical device industry has evolved through three major phases, with significant milestones including the first AI medical device approval in 2018 and the subsequent commercialization of deep learning-based products starting in 2020 [12][15]. Industry Chain Analysis - The industry chain consists of upstream hardware suppliers, midstream AI medical device manufacturers, and downstream application terminals [16]. - The number of clinical trial institutions for medical devices has increased, enhancing the regulatory environment and supporting industry growth [17][20]. Market Size and Growth - The AI medical device market is projected to grow significantly, driven by the increasing adoption of AI technologies in healthcare and the expansion of applications in various medical fields [30][33]. Policy Support - Government policies have been instrumental in promoting the development of the AI medical device industry, with various initiatives aimed at encouraging innovation and regulatory clarity [32][35]. Competitive Landscape - The competitive landscape of the AI medical device industry is structured into tiers, with leading companies such as Shukun Technology in the first tier, followed by companies like United Imaging and Infervision in the second tier [38][39].
中国空港行业市场规模测算逻辑模型 头豹词条报告系列
Tou Bao Yan Jiu Yuan· 2025-03-10 12:52
林芷仪 空港行业规模 中国空港行业市场规模测算逻辑模 型 头豹词条报告系列 | 1. 空港旅客吞吐量 (结论图 ) | P3 | | --- | --- | | 2. 空港旅客吞吐量 | P4 | | 3. 空港国内航线旅客吞吐量 | P5 | | 4. 空港国际航线旅客吞吐量 | P6 | | 5. 溯源信息链接引用 | P7 | | 6. 法律声明 | P8 | | 7. 头豹研究院简介 | P9 | | 8. 头豹词条介绍 | P10 | | 9. 头豹词条报告 | P11 | 1. 空港旅客吞吐量 (结论图) P3 2. 空港旅客吞吐量 P4 空港旅客吞吐量:(结论=A+B) 空港旅客吞吐量:(结论=A+B) | 年份 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 数据 | 1,147,867,0 | 1,264,688,0 | 1 ...
2024年一脉阳光企业研究:智能影像,精准医疗
Tou Bao Yan Jiu Yuan· 2025-03-10 12:52
企业研报 2024/11 www.leadleo.com 2024年一脉阳光企业研究: 智能影像,精准医疗 Rimag Imaging Hospital Group Enterprise Report リマグ・イメージング病院グループ企業報告 报告标签:医学影像,CT,MRI 主笔人:何婉怡 报告提供的任何内容(包括但不限于数据、文字、图表、图像等)均系头豹研究院独有的高度机密性 文件(在报告中另行标明出处者除外)。未经头豹研究院事先书面许可,任何人不得以任何方式擅自 复制、再造、传播、出版、引用、改编、汇编本报告内容,若有违反上述约定的行为发生,头豹研究 院保留采取法律措施、追究相关人员责任的权利。头豹研究院开展的所有商业活动均使用"头豹研究院 "或"头豹"的商号、商标,头豹研究院无任何前述名称之外的其他分支机构,也未授权或聘用其他任何 第三方代表头豹研究院开展商业活动。 团队介绍 郝世超 首席分析师 Lamber.Hao@Leadleo.com 何婉怡 行业分析师 Margaret.He@Leadleo.com 头豹研究院 咨询/合作 网址:www.leadleo.com 电话:18621660149(郝 ...
2025年头豹词条报告系列:AI医疗器械爆发前夜:医学影像与诊断设备引领千亿级市场变革
Tou Bao Yan Jiu Yuan· 2025-03-10 12:08
AI医疗器械爆发前夜:医学影像与诊断设备引领千亿级市场变革 头豹词条报告系列 2025-02-28 未经平台授权,禁止转载 摘要 AI医疗器械行业基于医疗器械数据,采用人工智能技术实现医疗用途。国家药监局颁布相关指导原则,规范行业生存周期过程。行业应用领域广泛,入局企业多样化,三类 证获批数量稳定增加。市场规模逐年扩大,得益于人工智能技术商业化落地、政策导向驱动及AI医疗器械逐步渗透至医疗机构及第三方影像中心。未来,随着更多领域产品 的获批上市及企业研发技术的深入,市场竞争将加剧,AI医疗器械行业市场前景广阔。 行业定义 人工智能医疗器械是指基于"医疗器械数据",采用人工智能技术实现其预期用途(即医疗用途)的医疗器械。而医疗器械数据是指医疗器械 产生的用于医疗用途的客观数据,如医学影像设备产生的医学图像数据、医用电子设备产生的生理参数数据等。 2022年3月,国家药监局颁布《人工智能医疗器械注册审查指导原则》,对人工智能医疗器械类型进行界定,并对人工智能医疗器械生存周 期过程,包括需求分析、数据收集、算法设计、验证确认、更新控制等环节做出了规定,并提供了16类技术考量因素。 行业分类 AI医疗器械的分类方式多 ...
2024年中国汉堡行业:健康风潮与快捷诉求下的破茧之路(摘要版)
Tou Bao Yan Jiu Yuan· 2025-03-07 15:12
报告标签:华莱士,塔斯汀,麦当劳,健康化 主笔人:王渝程 报告提供的任何内容(包括但不限于数据、文字、图表、图像等)均系头豹研究院独有的高度机密性 文件(在报告中另行标明出处者除外)。未经头豹研究院事先书面许可,任何人不得以任何方式擅自 复制、再造、传播、出版、引用、改编、汇编本报告内容,若有违反上述约定的行为发生,头豹研究 院保留采取法律措施、追究相关人员责任的权利。头豹研究院开展的所有商业活动均使用"头豹研究院 "或"头豹"的商号、商标,头豹研究院无任何前述名称之外的其他分支机构,也未授权或聘用其他任何 第三方代表头豹研究院开展商业活动。 行业概览 | 2024/11 观点摘要 www.leadleo.com 行业概览| 2024/11 2024年中国汉堡行业:健康风潮与快 节奏生活诉求下的破茧之路 2024 China Burger Industry Overview: The Way to Break the Cocoon under Health Trend and Rapid Pace Life 2024年中国ハンバーガー産業概況:健康傾向と急速な生 活の中での繭を打ち破る方法 (摘要版) 汉堡起 ...
过敏性疾病:国民健康意识渐增,驱动行业规模提升 头豹词条报告系列
Tou Bao Yan Jiu Yuan· 2025-03-07 15:12
过敏性疾病:国民健康意识渐增,驱动行业规模提升 头豹词 条报告系列 2025-02-28 未经平台授权,禁止转载 摘要 随着国民健康意识的增强和生活环境的变化,中国过敏性疾病的发病率逐年上升,推动了该领域的医疗需求增长和技术进步。过敏性疾病治疗药物是行业核心,目前本土企 业在化学药特别是抗组胺药领域已建立较为完善的研产体系,满足了大部分轻中度过敏性疾病的治疗需求。但面对复杂难治的重症病例,生物抗体治疗和免疫治疗仍是重点 治疗手段,也是行业未来发展的关键方向。随着生物技术创新持续推动,中国过敏性疾病行业有望实现更多的增长。 行业定义 过敏性疾病(AllergicDiseases,AD)是一种变态反应性炎症,简称变应性炎症。它是机体受一种或多种抗原物质刺激后,产生反应过程引起 有害的过度反应,属于免疫性疾病范畴。常见的过敏性疾病包括过敏性鼻炎、过敏性哮喘、特应性皮炎、食物过敏和药物过敏。过敏性疾病在过 去数十年里发病率显著上升,现已被WHO列为21世纪重点防治的三大疾病之一。过敏性疾病常见的过敏原包括:以花粉、皮毛和室内尘土为代 表的吸入性过敏原;以牛奶和虾为代表的食入性过敏原;以化妆品为代表的接触性过敏原;以青 ...
中国食用油行业市场规模测算逻辑模型 头豹词条报告系列
Tou Bao Yan Jiu Yuan· 2025-03-07 15:12
Investment Rating - The report does not explicitly provide an investment rating for the edible oil industry Core Insights - The total consumption of edible oil in China has shown fluctuations, with a projected consumption of 140.64 million kilograms in 2023, slightly decreasing to 140.6 million kilograms by 2027 [7][8] - The per capita consumption of edible oil has been relatively stable, with a slight decline from 10.7 kg in 2017 to an estimated 9.97 kg in 2023, indicating a trend towards stagnation in growth [8][12] - The population of China is expected to peak in 2022, with a gradual decline thereafter, which may impact the overall demand for edible oil [9][16] Summary by Sections Total Consumption of Edible Oil - The total consumption of edible oil in China from 2017 to 2027 shows a peak in 2021 at 142.71 million kilograms, followed by a slight decrease in subsequent years [7][8] Per Capita Consumption of Edible Oil - The per capita consumption of edible oil has decreased from 10.7 kg in 2017 to an estimated 9.97 kg in 2023, reflecting a compound annual growth rate (CAGR) of -1.4% from 2017 to 2022 [8][12] Population Data - The population of China has shown a slight increase from 14 billion in 2017 to an estimated 14.11 billion in 2023, but is projected to decline gradually after reaching its peak in 2022 [9][16]
过敏性疾病:国民健康意识渐增,驱动行业规模提升
Tou Bao Yan Jiu Yuan· 2025-03-07 13:01
Investment Rating - The report indicates a positive investment outlook for the allergic diseases industry, driven by increasing healthcare awareness and rising demand for treatment options. Core Insights - The prevalence of allergic diseases in China is on the rise, leading to increased medical demand and technological advancements in treatment options. The core of the industry lies in the development of therapeutic drugs, particularly antihistamines, with a focus on biologics and immunotherapy for severe cases as key future directions [1][2][3]. Industry Definition - Allergic diseases are characterized by hypersensitivity reactions to various antigens, classified into categories such as allergic rhinitis, allergic asthma, atopic dermatitis, food allergies, and drug allergies [2][3]. Industry Classification - The allergic diseases industry can be categorized based on specific conditions, including allergic rhinitis, allergic asthma, atopic dermatitis, food allergies, and non-food allergies [3]. Industry Characteristics - The industry features a variety of allergen detection methods and diverse treatment options, with a growing focus on IgE as a target for new therapeutic developments [8][9][10]. Development History - The establishment of specialized departments for allergic diseases in China marked the beginning of systematic research and treatment in this field, leading to significant advancements in understanding and managing allergic conditions [12][14][15]. Industry Chain Analysis - The allergic diseases industry consists of a supply chain that includes raw material suppliers, drug manufacturers, and distribution channels, with a notable focus on the development of antihistamine drugs and biologics [16][17][18]. Market Size - The market size for allergic diseases in China grew from 38.38 billion RMB in 2019 to 45.23 billion RMB in 2023, with a compound annual growth rate (CAGR) of 4.19%. Projections indicate growth to 77.87 billion RMB by 2028, with a CAGR of 11.09% [32][34]. Future Market Drivers - The innovation in antihistamines and the development of biologics are expected to drive continued growth in the allergic diseases market, with a focus on reducing side effects and improving patient adherence to treatment [35][36]. Competitive Landscape - The allergic diseases market is characterized by significant competition, with leading companies leveraging their financial resources for drug innovation and maintaining a diverse product line to meet patient needs [40][41][42].
企业竞争图谱:2025年新能源汽车电池盒箱体
Tou Bao Yan Jiu Yuan· 2025-03-07 12:25
Investment Rating - The report indicates a positive outlook for the new energy vehicle battery box industry, driven by increasing penetration rates and supportive national policies [1]. Core Insights - The new energy vehicle battery box is a critical component of the battery pack, characterized by high customer barriers, continuous upgrades with battery integration technology, and a strong correlation with the new energy vehicle industry [1][7][10]. - The market for new energy vehicle battery boxes is expected to grow significantly, with a projected compound annual growth rate (CAGR) of 76.59% from 2020 to 2024, increasing from 2.734 billion RMB to 26.586 billion RMB [27][28]. - The industry is transitioning towards lightweight and sustainable solutions, with innovations in battery integration technologies such as CTP and CTB expected to drive further growth [14][30]. Industry Definition - New energy vehicle battery boxes serve as the "skeleton" of the battery pack, requiring safety, protection, and sealing capabilities to ensure the normal operation of the battery system [2]. Industry Classification - The battery boxes can be classified based on battery system integration technologies into CTM, CTP, and CTC/CTB types [3][4][5][6]. Industry Characteristics - High customer barriers exist due to the need for collaboration among vehicle manufacturers, battery manufacturers, and battery box suppliers [7]. - The industry is closely linked to the new energy vehicle market, with market size directly correlated to the growth of new energy vehicles [10]. Development History - The market has evolved alongside the new energy vehicle industry, with significant growth observed post-2015 as CTP technology gained traction [11][13]. - The current phase emphasizes green and sustainable development, focusing on lightweight and environmentally friendly materials [14]. Industry Chain Analysis - The industry chain consists of upstream raw materials (aluminum alloys, carbon fiber composites), midstream manufacturing, and downstream applications primarily in electric and hybrid vehicles [15][25]. - Domestic companies dominate the market, leveraging local advantages to meet customer needs effectively [16]. Market Size - The market size is projected to grow from 27.34 billion RMB in 2020 to 265.86 billion RMB by 2024, with a CAGR of 76.59% [27]. - By 2029, the market is expected to reach 583.14 billion RMB, indicating sustained growth [27]. Competitive Landscape - The competitive landscape features a tiered structure, with leading companies like Sensata Technologies, Huayu Automotive, and New Aluminum Era holding significant market shares [36][37]. - Traditional automotive parts manufacturers have quickly entered the battery box market, leveraging existing production capabilities and customer relationships [37]. Company Overview - New Aluminum Era focuses on lightweight aluminum materials for automotive applications, holding a strong position in the market with significant R&D investments [39][41]. - The company has shown rapid revenue growth, with battery box revenue constituting a growing percentage of its total income [41].